UTAH MEDICAL PRODUCTS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Utah Medical Products Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Utah Medical Products Inc Operating Income (Loss) for the quarter ending June 30, 2024 was $3.44M, a 22.3% decline year-over-year.
  • Utah Medical Products Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was $15.2M, a 20.1% decline year-over-year.
  • Utah Medical Products Inc annual Operating Income (Loss) for 2023 was $16.8M, a 15.2% decline from 2022.
  • Utah Medical Products Inc annual Operating Income (Loss) for 2022 was $19.8M, a 4.82% increase from 2021.
  • Utah Medical Products Inc annual Operating Income (Loss) for 2021 was $18.9M, a 37.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $15.2M $3.44M -$987K -22.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $16.2M $3.88M -$556K -12.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $16.8M $3.94M -$1.13M -22.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $17.9M $3.97M -$1.17M -22.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $19.1M $4.43M -$632K -12.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $19.7M $4.44M -$83K -1.84% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $19.8M $5.07M -$59K -1.15% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $19.8M $5.14M +$43K +0.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $19.8M $5.06M +$292K +6.13% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $19.5M $4.52M +$634K +16.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $18.9M $5.13M +$848K +19.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-26
Q3 2021 $18M $5.1M +$1.51M +42.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $16.5M $4.77M +$2.79M +141% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $13.7M $3.89M +$25K +0.65% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $13.7M $4.28M -$398K -8.51% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-28
Q3 2020 $14.1M $3.59M -$784K -17.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $14.9M $1.98M -$2.5M -55.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $17.4M $3.86M -$238K -5.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $17.6M $4.68M +$411K +9.63% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-25
Q3 2019 $17.2M $4.37M -$31K -0.7% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-09
Q2 2019 $17.3M $4.48M -$575K -11.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $17.8M $4.1M -$870K -17.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $18.7M $4.27M -$305K -6.67% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-26
Q3 2018 $19M $4.4M -$277K -5.92% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $19.3M $5.06M +$22K +0.44% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $19.3M $4.97M +$246K +5.21% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $19M $4.57M +$952K +26.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $18.1M $4.68M +$740K +18.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $17.3M $5.03M +$719K +16.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $16.6M $4.73M +$413K +9.58% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $16.2M $3.62M -$186K -4.89% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $16.4M $3.94M -$61K -1.53% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $16.4M $4.32M +$348K +8.77% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $16.1M $4.31M +$435K +11.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $15.7M $3.81M -$488K -11.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $16.1M $4M -$2K -0.05% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $16.1M $3.97M -$95K -2.34% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $16.2M $3.88M +$34K +0.89% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $16.2M $4.3M +$736K +20.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-08
Q3 2014 $15.5M $4M +$337K +9.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $15.1M $4.06M +$347K +9.34% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $14.8M $3.84M -$46K -1.18% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $14.8M $3.56M -$10K -0.28% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $14.8M $3.67M -$295K -7.45% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $15.1M $3.72M +$163K +4.59% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $15M $3.89M -$226K -5.49% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $15.2M $3.57M +$657K +22.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $14.5M $3.96M +$421K +11.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $14.1M $3.55M +$319K +9.87% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $13.8M $4.12M +$1.96M +90.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $11.8M $2.91M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 $3.54M +$1.28M +56.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $3.23M +$1.04M +47.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $2.16M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $2.26M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $2.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.